Triveni Bio Inc.
- Address
- 99 Coolidge Avenue Suite 450
Sponsor Overview
Specializations
Atopic Dermatitis
Triveni Bio Inc. focuses its clinical research on atopic dermatitis, with studies centered on adults living with moderate to severe disease. The sponsor’s work in this area reflects a therapeutic interest in inflammatory skin disorders and the restoration of skin health.
- Skin barrier function
- Inflammatory skin disease
- Moderate to severe atopic dermatitis
Its research activity includes evaluation of treatment effects on cutaneous symptoms and barrier integrity, indicating a clear focus on dermatologic disease mechanisms and patient-relevant outcomes.
Dermatology Therapeutics
The sponsor’s clinical portfolio is concentrated in dermatology, particularly therapies intended to address chronic inflammatory conditions affecting the skin. This includes interest in interventions designed for symptomatic control and improvement of skin condition.
- Chronic inflammatory dermatoses
- Skin health
- Adult patient populations
Research activity in this domain supports development efforts aimed at improving disease-specific outcomes in atopic skin disease.
Immunology
Triveni Bio Inc. is engaged in clinical investigation of immune-mediated skin disease, reflecting an interest in the immunologic basis of atopic dermatitis. The sponsor’s studies align with therapeutic areas where immune dysregulation contributes to persistent skin inflammation.
- Immune-mediated inflammation
- Atopic disease
- Inflammatory response
This area of research places emphasis on conditions where immune pathways are closely linked to disease burden and clinical symptoms.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 2a, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Multiple Subcutaneous Doses of TRIV-509 in Adults with Moderate to Severe Atopic Dermatitis |  Bulgaria Czechia Hungary Poland | Not Recruiting |
| A Randomized, Double‑Blind, Placebo‑Controlled Trial Assessing TRIV‑509 on Skin Barrier Function in Adults with Atopic Dermatitis |  The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 24 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases2 trials247 other sponsors
Partnered Research Centres
24 centres- Address
- 28. Rijna 3348/65, Moravska Ostrava, 702 00 Moravska Ostrava A Privoz
- Address
- Zernikedreef 8, 2333 CL Leiden
- Address
- Ul. Gabrieli Zapolskiej 3, 41-218 Sosnowiec
- Address
- Kaszasdulo Utca 5, 1033 Budapest
- Address
- Ul. Feliksa Nowowiejskiego 5, 61-731 Poznan
- Address
- ulica sw. Barbary 14, 41-500 Chorzów
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Triveni Bio Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.